What has been the forum's experience with TSM and HMVTR's? I have used the Op Site IV 3000 for many years and have had great outcomes. We are currently using Tegaderm at our hospital and I was always taught that it's completely occlusive. TSM's such as Op Site and Sorbaview have HMVTR's and have worked well for me in the past at PICC/CVC sites. What has been your experience with TSM's? What has worked for you? What hasn't worked for you? Any feedback would be appreciated!
Marty Quinton, RN, BSN, CRNI
PICC Nurse
Methodist Germantown Hospital
Germantown, TN
The feature of moisture vapor transmission rate was not a factor in the draft guidelines released by CDC last Nov. This is really old news. Since the CDC paid no attention to this one can only assume that there is not enough data to show that this does anything to reduce the risk of infection. We have moved on now to the CHG impregnated dressings. What other benefits do you see? Lynn
Lynn Hadaway, M.Ed., RN, NPD-BC, CRNI
Lynn Hadaway Associates, Inc.
PO Box 10
Milner, GA 30257
Website http://www.hadawayassociates.com
Office Phone 770-358-7861
Lynn
Instead of expecting staff to remember to drop and then properly apply a Biopatch and in an effort to
centralize and simplify we were asked to evaluate the 3M CHG Dressing to be included in our CVC dressing kit
We are now being told that the 2 products are not comprable
Is this Rep speak or an Evidence-Based fact?
Robbin George RN Vascular Access Resource Dept Alexandria Hospital Virginia
Robbin George RN VA-BC
I am not exactly sure from the limit amount of information you provided what was used to make the statement that the CHG sponge dressing and the CHG gel dressing "are not comparable." The 2 devices have different designs for sure. To my knowledge there has not been a clinical study comparing the clinical outcomes of these 2 products. So know one really knows if the clinical outcomes from these products are equal or if one does perform better than the other. Clinical decisions are about the evidence which most often includes a variety of types of studies on patients. In vitro studies may enter the picture when there are no clinical or patient studies to use but I would also expect this to change as more studies become available. And the studies should be published in a respected journal with a blinded peer reviewed process. A study published by the manufacturer is called a "white paper", is for the purpose of markeing the product, and has not been through any blinded peer review process. So when any sales rep makes similar statements, I would totally expect them to support that statement with research, preferably in vivo, clinical evidence on patients instead of in vitro or lab studies. Lynn
Lynn Hadaway, M.Ed., RN, NPD-BC, CRNI
Lynn Hadaway Associates, Inc.
PO Box 10
Milner, GA 30257
Website http://www.hadawayassociates.com
Office Phone 770-358-7861